A Comprehensive Review on the Application of Artificial Intelligence for Predicting Postsurgical Recurrence Risk in
Ghazal Mehri-Kakavand1, Sibusiso Mdletshe1, Alan Wang1,2,3,4,5,6
1Department of Anatomy and Medical Imaging, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
Journal of Medical Radiation Sciences
|January 23, 2025
Summary
Artificial intelligence (AI) shows promise in predicting non-small cell lung cancer (NSCLC) recurrence after surgery using imaging and clinical data. Further research is needed to develop robust AI models for improved patient outcomes.
Area of Science:
- Oncology
- Radiology
- Medical Informatics
Background:
- Non-small cell lung cancer (NSCLC) is a leading cause of cancer mortality worldwide.
- Postsurgical recurrence affects 30%-55% of early-stage NSCLC patients within five years.
- Predicting recurrence risk is crucial for improving patient management and outcomes.
Purpose of the Study:
- To review the utilization of artificial intelligence (AI) for predicting postsurgical recurrence risk in early-stage NSCLC.
- To analyze studies incorporating CT, PET, and clinical data for recurrence prediction.
- To identify current challenges and future directions in AI-driven recurrence prediction.
Main Methods:
- Literature search of studies published between 2018-2024.
- Focus on radiomics, machine learning, and deep learning using preoperative PET, CT, and PET/CT data.
- Inclusion of studies with or without clinical data integration; methodological quality assessed using METRICS.
Main Results:
- AI and radiomics models demonstrate potential in predicting postsurgical recurrence risk.
- Promising results observed with handcrafted radiomics features, deep learning, and multimodal models.
- Identified challenges include small sample sizes, lack of external validation, and interpretability issues.
Conclusions:
- Future research requires larger, prospective, multicenter studies for robust AI model development.
- Improving data integration, interpretability, and fusion of imaging modalities is essential.
- Standardizing methodologies and fostering collaboration will advance clinical utility and patient care.


